"We engage Paracelsus at Aires (and did so at our previous company, Palkion) and have been very pleased with Dr. Furman’s knowledge, expertise, advice, timeliness, and work ethic..."
Aires Pharmaceuticals
Hiroko Masamune, PhD

Company Profile

The comprehensive nonclinical testing program required to support clinical development and ultimate registration of a novel therapeutic involves years of work and many different types of studies. This nonclinical program - which begins prior to initiation of clinical trials and often continues after a drug is approved for marketing - is an essential component of the pharmaceutical R&D process and represents a considerable financial investment to the innovator.

Proficient design and support of nonclinical testing programs requires a customized and integrative strategy that is relevant to the intended clinical indication and acceptable to global health authorities.

Paracelsus can help your organization successfully meet this challenge by offering a range of professional consulting services.  Discipline-specific expertise in key areas such as toxicology, veterinary pathology, pharmacology, pharmacokinetics, and regulatory affairs (strategic and operational) is available to Paracelsus clients through highly knowledgeable and experienced professionals.